drugset / Trial / NCT00154089
A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia
Phase 1/2
Completed
8 enrolled
Erimos Pharmaceuticals
Planned Parenthood Delaware (Wilmington, DE) · collabUniversity of Maryland, Baltimore County · collab
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to determine pilot safety and efficacy data for a topical formulation of EM-1421 applied to the cervix of patients with CIN 1, 2, or 3.
Timeline
- Start
- 2004-11
- Primary completion
- 2006-04
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Terameprocol | Small molecule | 45 mg | Other |
| Subject | Terameprocol | Small molecule | 90 mg | Other |